6.
Rafieian F, Amani R, Rezaei A, Can Karaca A, Jafari S
. Exploring fennel (): Composition, functional properties, potential health benefits, and safety. Crit Rev Food Sci Nutr. 2023; 64(20):6924-6941.
DOI: 10.1080/10408398.2023.2176817.
View
7.
Kamel A, Abdelkader N, Abd El-Rahman S, Emara M, Zaki H, Khattab M
. Stimulation of ACE2/ANG(1-7)/Mas Axis by Diminazene Ameliorates Alzheimer's Disease in the D-Galactose-Ovariectomized Rat Model: Role of PI3K/Akt Pathway. Mol Neurobiol. 2018; 55(10):8188-8202.
DOI: 10.1007/s12035-018-0966-3.
View
8.
Katariya R, Mishra K, Sammeta S, Umekar M, Kotagale N, Taksande B
. Agmatine mitigates behavioral abnormalities and neurochemical dysregulation associated with 3-Nitropropionic acid-induced Huntington's disease in rats. Neurotoxicology. 2024; 102:12-28.
DOI: 10.1016/j.neuro.2024.03.002.
View
9.
Morton H, Kshirsagar S, Orlov E, Bunquin L, Sawant N, Boleng L
. Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse. Free Radic Biol Med. 2021; 172:652-667.
DOI: 10.1016/j.freeradbiomed.2021.07.013.
View
10.
Afsar A, Chacon Castro M, Soladogun A, Zhang L
. Recent Development in the Understanding of Molecular and Cellular Mechanisms Underlying the Etiopathogenesis of Alzheimer's Disease. Int J Mol Sci. 2023; 24(8).
PMC: 10138573.
DOI: 10.3390/ijms24087258.
View
11.
Keshri P, Singh S
. Unraveling the AKT/ERK cascade and its role in Parkinson disease. Arch Toxicol. 2024; 98(10):3169-3190.
DOI: 10.1007/s00204-024-03829-9.
View
12.
Long H, Cheng Y, Zhou Z, Luo H, Wen D, Gao L
. PI3K/AKT Signal Pathway: A Target of Natural Products in the Prevention and Treatment of Alzheimer's Disease and Parkinson's Disease. Front Pharmacol. 2021; 12:648636.
PMC: 8082498.
DOI: 10.3389/fphar.2021.648636.
View
13.
Cai B, Wang Q, Zhong L, Liu F, Wang X, Chen T
. Integrating Network Pharmacology, Transcriptomics to Reveal Neuroprotective of Curcumin Activate PI3K / AKT Pathway in Parkinson's Disease. Drug Des Devel Ther. 2024; 18:2869-2881.
PMC: 11246089.
DOI: 10.2147/DDDT.S462333.
View
14.
Colucci-DAmato L, Speranza L, Volpicelli F
. Neurotrophic Factor BDNF, Physiological Functions and Therapeutic Potential in Depression, Neurodegeneration and Brain Cancer. Int J Mol Sci. 2020; 21(20).
PMC: 7589016.
DOI: 10.3390/ijms21207777.
View
15.
Wang X, Wang Y, Zhu Y, Yan L, Zhao L
. Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer's Disease. Drug Des Devel Ther. 2019; 13:4053-4063.
PMC: 6890185.
DOI: 10.2147/DDDT.S233283.
View
16.
Kim S, Ullah I, Beloor J, Chung K, Kim J, Yi Y
. Systemic Treatment with siRNA Targeting Gamma-Secretase Activating Protein Inhibits Amyloid-β Accumulation in Alzheimer's Disease. Biomater Res. 2024; 28:0027.
PMC: 11168191.
DOI: 10.34133/bmr.0027.
View
17.
Li X, Teng T, Yan W, Fan L, Liu X, Clarke G
. AKT and MAPK signaling pathways in hippocampus reveals the pathogenesis of depression in four stress-induced models. Transl Psychiatry. 2023; 13(1):200.
PMC: 10261007.
DOI: 10.1038/s41398-023-02486-3.
View
18.
Liu R, Liu N, Ma L, Liu Y, Huang Z, Peng X
. Research Progress on NMDA Receptor Enhancement Drugs for the Treatment of Depressive Disorder. CNS Drugs. 2024; 38(12):985-1002.
DOI: 10.1007/s40263-024-01123-x.
View
19.
Vastegani S, Khoshnam S, Mansouri E, Ghafouri S, Bakhtiari N, Farbood Y
. Anti-inflammatory, anti-apoptotic, and neuroprotective potentials of anethole in Parkinson's disease-like motor and non-motor symptoms induced by rotenone in rats. Metab Brain Dis. 2023; 38(6):2159-2174.
DOI: 10.1007/s11011-023-01230-6.
View
20.
Goel R, Bhat S, Hanif K, Nath C, Shukla R
. Angiotensin II Receptor Blockers Attenuate Lipopolysaccharide-Induced Memory Impairment by Modulation of NF-κB-Mediated BDNF/CREB Expression and Apoptosis in Spontaneously Hypertensive Rats. Mol Neurobiol. 2017; 55(2):1725-1739.
DOI: 10.1007/s12035-017-0450-5.
View